Ellen Lubman

Founder, Bella Biotech Advisory

Ellen-LubmanEllen Lubman is the Founder of Bella Biotech Advisory, a strategic and business development advisory based in New York and Los Angeles. Previously, she was the Vice President of Strategy & Innovation at Forest Laboratories in New York City. Prior to Forest, Ellen was the Senior Vice President of Corporate Development at NY-based Kadmon Pharmaceuticals. Prior to joining Kadmon, Ellen was a Group Director in the Strategic Transactions Group and Global Mergers & Acquisitions Lead at Bristol-Myers Squibb where she focused on Mergers and Acquisitions, identification of new transaction opportunities, and initiation of “String of Pearls” transactions, as well as spearheading novel business initiatives and venture capital outreach. Prior to joining Bristol-Myers Squibb, Ellen worked with Celtic Pharma, L.P., a private equity fund that acquires direct ownership or controlling stakes in commercially attractive pharmaceutical products in the late stages of clinical and regulatory development, and VIA Pharmaceuticals, a start-up cardiovascular disease biotechnology company incubated at Bay City Capital in San Francisco. During business school, she spend her summer internship with the Amgen Licensing team and helped the Eastern Europe team at Roche create a plan to advance their subsidiaries into independent operating entities. During the heyday of the Human Genome Project, Ellen was a Biotechnology Equity Research Analyst at Robertson Stephens where she covered over 20 companies with a focus on Genomics, Proteomics, Drug Discovery and Technology Platform companies, and developed research pieces on Genetic Intellectual Property, Single Nucleotide Polymorphisms and other discovery technologies. Ellen holds a bachelor’s degree in Biological Sciences from Rutgers College and an MBA from the Stanford Graduate School of Business, including a Certificate in Global Management. She is a member of Springboard Enterprises and New York Academy of Sciences, and is actively involved in Gilda’s Club of New York, a cancer charity. Ellen was born in Kiev, Ukraine and is a native Russian speaker.